An open-label, randomized, multi-center study to evaluate the use of Study Drug in the prevention of cancer treatment-related bone loss in post-menopausal women with ER+ and/or PR+ breast cancer receiving letrozole as adjuvant therapy.
Explore related content and topics
Blog
Is Marijuana a Replacement for Opioids?
Read Story
Blog
Bridging Recruitment Gaps with Academic Collaboration
Read Story
Webcast
THE INSIGHT SERIES: Is there any way to expedite the start-up processes for global non-interventional research? - Part 5
When new drugs are approved, the marketing authorization holders often have to commit themselves to perform additional post-authorization studies.…
View Resource
View all related content and resources for Real World Solutions
Explore Insights